期刊文献+

维生素D对急性肾损伤的保护作用研究

The Protective Effect of Vitamin D on Acute Kidney Injury
下载PDF
导出
摘要 急性肾损伤(AKI)是一组以肾小球滤过率迅速下降为特征的临床综合征。临床检验标准是血清肌酐和尿素氮的快速升高。AKI是一种常见的急性疾病,尽管临床应用了许多策略,但其发病率和死亡率高,预后差。维生素D不仅是一种钙磷调节激素,还被称为肾保护剂,通过抑制氧化应激、炎症反应、足细胞凋亡及肾纤维化,降低尿蛋白,延缓肾脏进展,保护肾功能。本文探讨维生素D对急性肾损伤的保护作用,为AKI的诊断和治疗提供更多的理论依据。 Acute kidney injury(AKI)is a group of clinical syndromes characterized by rapid decline of glomerular filtration rate.The clinical test standard is the rapid increase of serum creatinine and urea nitrogen.AKI is a common acute disease.Although many strategies have been applied in clinic,its incidence rate and mortality rate are high and its prognosis is poor.Vitamin D is not only a calcium and phosphorus regulatory hormone,but also known as renal protective agent.It can inhibit oxidative stress,inflammatory response,podocyte apoptosis and renal fibrosis,reduce urinary protein,delay renal progression and protect renal function.This paper discusses the protective effect of vitamin D on acute kidney injury,so as to provide more theoretical basis for the diagnosis and treatment of AKI.
作者 徐宁 陈学勋 郭民 李香玲 XU Ning;CHEN Xuexun;GUO Min;LI Xiangling(Weifang Medical University,Weifang 261053,China;不详)
出处 《中国医学创新》 CAS 2022年第23期181-184,共4页 Medical Innovation of China
基金 潍坊市科技发展计划项目(2018YX023) 山东省医药卫生科技发展计划项目(2017ws404)。
关键词 维生素D 急性肾损伤 急性肾衰竭 炎症 Vitamin D Acute kidney injury Acute renal failure Inflammation
  • 相关文献

参考文献1

二级参考文献17

  • 1Li JJ, Kwak SJ, Jung DS, et al. Podocyte biology in diabetic nephropathy[J]. Kidney Int Suppl, 2007, 106:S36-S42.
  • 2Wada J, Makino H. Inflammation and the pathogenesis of diabetic nephropathy[J]. Clin Sci (Lond), 2013, 124: 139-152.
  • 3Jefferson JA, Shankland SJ, Pichler RH. Proteinuria in diabetic kidney disease: a mechanistic viewpoint[J]. Kidney Int, 2008, 74: 22-36.
  • 4Wang G, Lai FM, Lai KB, et al. Urinary messenger RNA expression of podocyte- associated molecules in patients with diabetic nephropathy treated by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker[J]. Eur J Endoerinol,2008, 158: 317-322.
  • 5Cheng J, Zhang W, Zhang X, et al. Efficacy and safety of paricalcitol therapy for chronic kidney disease: a meta-analysis [J]. Clin J Am Soc Nephrol, 2012, 7: 391-400.
  • 6Deb DK, Sun T, Wong KE, et al. Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes[J]. Kidney Int, 2010, 77: 1000-1009.
  • 7He W, Kang YS, Dai C, et al. Blockade of Wnt/beta- catenin signaling by paricalcitol ameliorates proteinuria and kidney injury[J]. J Am Soc Nephrol, 2011, 22: 90-103.
  • 8Deb DK, Chen Y, Zhang Z, et al. 1,25-Dihydroxyvitamin D3 suppresses high glucose-induced angiotensinogen expression in kidney cells by blocking the NF- {kappa}B pathway[J]. Am J Physiol Renal Physiol, 2009, 296: F1212-F1218.
  • 9Ricardo SD, van Goor H, Eddy AA. Macrophage diversity in renal injury and repair[J], J Clin Invest, 2008, 118: 3522-3530.
  • 10Eardley KS, Zehnder D, Quinkler M, et al. The relationship between albuminuria, MCP - 1/CCL2, and interstitial macrophages in chronic kidney disease[J]. Kidney Int, 2006, 69: 1189-1197.

共引文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部